Managers

DG12 not raising venture fund: Correction

DG12 is not raising a venture-capital fund, according to angel investor Lee Linden.

Refuge Biotechnologies racks up $25 mln Series B

Menlo Park, California-based Refuge Biotechnologies Inc, a developer of intelligent cell therapies to combat cancer, has secured $25 million in Series B funding. The lead investors were 3SBio and Sequoia China. Also, participating in the round were Danhua Capital, Sangel Capital, Ocean Pine Healthcare Fund, 3E Bioventures, WuXi Healthcare Ventures and ShangBay Capital. In addition to the funding, Dr. Zhenping Zhu of 3SBio and Dr. Trency Gu of Sequoia China, have joined the Refuge board of directors.

Azitra pockets $2.15 mln

Farmington, Connecticut-based Azitra Inc, a biotech company focused on harnessing the microbiome to treat skin disease, has raised $2.15 million in financing. Connecticut Innovations and Bios Partners were the lead investors. Also, KdT Ventures participated in the round.

Avedro lands $25 mln

Avedro Inc, an ophthalmic pharmaceutical and medical device company, has secured $25 million in financing. Lilly Asia Ventures led the round with participation from return backers OrbiMed Advisors, InterWest Partners and HealthQuest Capital.

Rapid Micro Biosystems scores $60 mln

Rapid Micro Biosystems, a provider of rapid microbial detection technology for the healthcare product manufacturing sector, has secured $60 million in financing. Bain Capital Life Sciences and Xeraya Capital led the round with participation from Asahi Kasei Medical, Longitude Capital, Quaker Partners, TVM Capital and Richard K. Mellon and Sons. Locust Walk provided financial advice to Rapid Micro Biosystems on the transaction.

Cryptocurrency-backed venture fund Pithia invests in digital-ID company Trusted Key

OCGC commits $55 mln to Yaletown, Emerald funds

Ontario Capital Growth Corp (OCGC), the venture capital agency of the Ontario government, has invested in two venture capital firms as part of its mandate to support the growth of clean technology companies in the province. OCGC committed $20 million to Yaletown Innovation Growth Fund, the emerging-growth technology fund of Canadian firm Yaletown Partners. It also committed $35 million to the Canadian energy technology fund of European firm Emerald Technology Ventures. In December, PE Hub Canada reported on the initial close of the Yaletown fund at more than $100 million.

Wavemaker Three-Sixty Health targets $25 mln for fund

Wavemaker Three-Sixty Health is seeking to raise $25 million for its new fund, according to an SEC filing. The Pasadena, California-based early-stage venture firm is focused on the healthcare industry.

Cybersecurity investments fall sharply in Q1

Goodwater Capital to raise $350 mln for third fund

Goodwater Capital has set a $350 million target for its third fund, according to an SEC filing. The San Mateo, California-based venture firm invests in consumer tech startups.